Aggregated China Business Blogs



Unigene Enters Joint Venture for Osteoporosis Drug

Aggregated Source: China Stocks News and Analysis from Seeking Alpha
January 8, 2008|


Unigene (UGNE.OB) will establish a joint venture in China with Shijiazhuang Pharma that will use a biologic process to produce Fortical, a nasal spray formulation of calcitonin salmon indicated for osteoporosis.

Original URL: Click here to visit original article
Copyright China Stocks News and Analysis from Seeking Alpha

Print This Post Print This Post | Email This Page Email This Page
No Ratings Yet
Loading ... Loading ...

Related Info:
  • China Osteoporosis Trends Favor Tongjitang Medicines
  • Tongjitang's Osteoperosis Drug Likely to Win FDA Approval
  • ZTE Enters Energy Market With RMB300 Million
  • Groupe Danone Exits Joint Venture With Mengniu In China
  • Toshiba Acquires 10% Stake Of Its Joint Venture In China For JPY200 Million

    • No Comments Yet »

    Your comment

    The following HTML tags are permitted:
    <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>

    RSS RSS Feed for Comments on this Post |